Showing results (1201-1210 of 1,523) with videos related to
Sort By:
Pageof 153
Lung Cancer (Amsterdam, Netherlands)|February 19, 2017
Efficacy according to blind independent central review: Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin/paclitaxel in Asian patients with EGFR mutation-positive advanced NSCLCYi-Long Wu, Nagahiro Saijo, Sumitra Thongprasert, et al.Plos One|July 7, 2012
Identification of enriched driver gene alterations in subgroups of non-small cell lung cancer patients based on histology and smoking statusShe-Juan An, Zhi-Hong Chen, Jian Su, et al.Lancet (London, England)|April 9, 2019
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trialTony S K Mok, Yi-Long Wu, Iveta Kudaba, et al.Nature Biomedical Engineering|May 23, 2025
Tension-induced directional migration of hepatic stellate cells potentially coordinates liver fibrosis progressionLyu Zhou, Ziao Shi, Xuesi Yang, et al.Plos One|November 1, 2014
Hepatocyte growth factor modification enhances the anti-arrhythmic properties of human bone marrow-derived mesenchymal stem cellsJian Zhang, Lin-Lin Wang, Wei Du, et al.Cell Death Discovery|October 21, 2020
Correction: Gut microbiota patterns associated with somatostatin in patients undergoing pancreaticoduodenectomy: a prospective studyGuan-Qun Li, Tao Zhang, Wei-Guang Yang, et al.Frontiers in Cellular and Infection Microbiology|May 8, 2023
Metagenomic next-generation sequencing and proteomics analysis in pediatric viral encephalitis and meningitisYi-Long Wang, Xiao-Tong Guo, Meng-Ying Zhu, et al.Clinical Lung Cancer|October 18, 2024
FLAIR: A Phase II, Open Label, Randomized Study of Osimertinib Plus Bevacizumab Versus Osimertinib in Recurrent or Metastatic Treatment-Naïve NSCLC Patients Harboring EGFR 21L858R MutationQing Zhou, Jie Li, Shun-Dong Cang, et al.Journal for Immunotherapy of Cancer|July 18, 2023
Immune suppressive microenvironment in liver metastases contributes to organ-specific response of immunotherapy in advanced non-small cell lung cancerJia-Yi Deng, Qing Gou, Lingling Yang, et al.World Journal of Pediatrics : WJP|December 12, 2022
Proteomic profiling of cerebrospinal fluid in pediatric myelin oligodendrocyte glycoprotein antibody-associated diseaseYi-Long Wang, Meng-Ying Zhu, Zhe-Feng Yuan, et al.Pageof 153